Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...

The study suggests that omalizumab could become a safer, more effective alternative to OIT for people with highly sensitive ...

Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...

The type of tick most commonly known to carry the bacterium that causes Lyme disease has been identified in eastern Montana, according to new National Institutes of Health (NIH) research. […] ...

Dr. Jay Bhattacharya, who opposed Covid lockdowns, is set to appear at a Senate confirmation hearing on Wednesday for his ...

Mosquitoes use their sense of smell and taste to find and feed on humans, spreading diseases like dengue. These sensory ...

Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...

A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers. The ...

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...

Dr. Collins, a renowned geneticist, ran the National Institutes of Health for 12 years. His parting statement offered a ...